Myocardial Revascularization in COVID-19 Era

Sasmojo Widito

doi:10.21776/ub.hsj.2021.002.03.1

Abstract

Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). More discussion is required to achieve the balance between clinical benefit and risk in the treatment of acute coronary syndrome (ACS) patients with COVID-19. The current COVID-19 pandemic prompts the need to evaluate criteria for indication and efficacy of the general safety protocols and particular cardiac catheterization laboratory (CCL) procedures to safeguard the patient and healthcare professionals

Highlights

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome (SARS-CoV-2) virus has been at pandemic levels since March 2020
acute coronary syndrome (ACS) encompasses a wide range of clinical manifestations, from ST-segment elevation myocardial infarction (STEMI) to Non-ST-segment elevation Acute Coronary Syndrome (NSTE-ACS), which includes NSTEMI and unstable angina pectoris (UAP)
Similar to STEMI patients with a confirmed or suspected case of COVID-19, NSTE-ACS patients presenting with unstable hemodynamic signs without the signs and symptoms of severe pneumonia, invasive strategy is recommended in isolated Cardiac Catheterization Laboratory (CCL) if the benefits of revascularization outweigh the risks

Summary

Introduction

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome (SARS-CoV-2) virus has been at pandemic levels since March 2020. The Covid-19 pandemic had a significant impact on healthcare, involving the management of acute coronary syndrome (ACS). ACS encompasses a wide range of clinical manifestations, from ST-segment elevation myocardial infarction (STEMI) to Non-ST-segment elevation Acute Coronary Syndrome (NSTE-ACS), which includes NSTEMI and unstable angina pectoris (UAP). There is still a concern that the public would delay seeking emergency help due to the worry of contracting COVID-19 in health facilities.[1,2] It might cause serious consequences, in conditions including acute coronary syndrome (ACS), where prompt treatment and coronary revascularization have been shown to reduce mortality and morbidity. Isolated reports were disclosed by local and regional authorities that the current pandemic is linked to a reduction in both presentations with acute myocardial infarction and revascularization procedures during the pandemic. In the event of a highly contagious pandemic, healthcare workers must remain vigilant and adhere to all safety precautions when within CCL.[3,4]

Revascularization

Cath Lab Operation

Conclusion